Brazil's EMS and India's Torrent Pharma vying for Sanofi's generic drugs: sources

LONDON/FRANKFURT (Reuters) - Brazilian drugs firm EMS and Indian rival Torrent Pharma have emerged as the only industry bidders for Sanofi's generic drugs unit, battling a series of buyout funds for an asset worth as much as $2.4 billion, sources familiar with the matter told Reuters.